Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Causes and Control

• Publication date

  2015-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10552-015-0695-0PMID 26589415PMCID PMC4724283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex Steroid Hormone Metabolism in Relation to Risk of Aggressive Prostate Cancer

  2014cited by this paper
• Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.

  2014cited by this paper
• Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent

  2013cited by this paper
• Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases.

  2013cited by this paper
• Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.

  2012cited by this paper
• Associations of Serum Sex Steroid Hormone and 5α-Androstane-3α,17β-Diol Glucuronide Concentrations with Prostate Cancer Risk Among Men Treated with Finasteride

  2012cited by this paper
• Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men

  2012cited by this paper
• Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

  2011cited by this paper
• Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort

  2010cited by this paper
• Transition of a Clinical Trial into Translational Research: The Prostate Cancer Prevention Trial Experience

  2010cited by this paper
• Sex hormones and the risk of incident prostate cancer.

  2010cited by this paper
• Androgens and the molecular epidemiology of prostate cancer

  2008cited by this paper
• Androgen and Prostate Cancer: Is the Hypothesis Dead?

  2008cited by this paper
• Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.

  2008cited by this paper
• Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.

  2007cited by this paper
• Molecular epidemiology of prostate cancer: hormone-related genetic loci.

  2007cited by this paper
• 92 TISSUE AND SERUM LEVELS OF PRINCIPAL ANDROGENS IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER

  2007cited by this paper
• Endogenous sex hormones and the risk of prostate cancer: A prospective study

  2007cited by this paper
• Sex steroid hormones in young manhood and the risk of subsequent prostate cancer: a longitudinal study in African-Americans and Caucasians (United States)

  2006cited by this paper
• Circulating Steroid Hormones and the Risk of Prostate Cancer

  2006cited by this paper
• Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era

  2005cited by this paper
• Androgen deprivation therapy for prostate cancer.

  2005cited by this paper
• The influence of finasteride on the development of prostate cancer.

  2003cited by this paper
• Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

  2002cited by this paper
• Prospective study of sex hormone levels and risk of prostate cancer.

  1996cited by this paper
• Serum androgens and prostate cancer.

  1996cited by this paper
• Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.

  1993cited by this paper
• 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

  1992cited by this paper
• Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone

  1982cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper

• Exploring the link between sex hormone-binding globulin levels and prostate cancer risk: a comprehensive systematic review and meta-analysis

  2025cites this paper
• Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

  2023cites this paper
• Association of Prudent, Western, and Alternate Healthy Eating Index (AHEI-2010) dietary patterns with serum testosterone and sex hormone binding globulin levels in men

  2022cites this paper
• Sex Steroid Hormones in Urinary Exosomes as Biomarkers for the Prediction of Prostate Cancer.

  2022cites this paper
• DAPL1 is a novel regulator of testosterone production in Leydig cells of mouse testis

  2021cites this paper
• Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.

  2021cites this paper
• The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial

  2020cites this paper
• Association of Long-Term Dynamics in Circulating Testosterone with Serum PSA in Prostate Cancer-Free Men with Initial-PSA < 4 ng/mL

  2019cites this paper
• Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency

  2019cites this paper
• Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy

  2019cites this paper
• Racial/Ethnic Differences in the Association Between Energy Balance and Prostate Cancer

  2018cites this paper
• Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach

  2018cites this paper
• Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

  2018cites this paper
• Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency.

  2018cites this paper
• Additional value of the ratio of serum total testosterone to total prostate‐specific antigen in the diagnosis of prostate cancer in a Chinese population

  2018cites this paper
• Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men

  2017cites this paper
• Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations

  2017cites this paper
• Chapter 35 – Nutrition and Prostate Cancer

  2017cites this paper
• Circulating steroid hormone variations throughout different stages of prostate cancer.

  2017cites this paper
• Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men

  2017cites this paper
• Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study

  2017cites this paper
• Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers

  2017cites this paper
• Association between age‐related reductions in testosterone and risk of prostate cancer—An analysis of patients' data with prostatic diseases

  2017cites this paper
• Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial

  2016cites this paper